Publication of clinical trial results evaluating TH-001 (PreDiaWell®) in Digital Health
Publication of clinical trial results evaluating TH-001 (PreDiaWell®) in Digital Health We are pleased to announce the publication of the […]
Publication of clinical trial results evaluating TH-001 (PreDiaWell®) in Digital Health We are pleased to announce the publication of the […]
PreDiaWell® Achieves ORCHA Certification with an Outstanding 95% Score We are delighted to announce that PreDiaWell® has successfully passed ORCHA
Tesu Health to Present Clinical Trial Results at ATTD 2025 Tesu Health is pleased to announce its participation in the
Positive Topline Results from the TH001_1001 Clinical Trial Evaluating PreDiaWell® in Adults with Prediabetes We are pleased to announce positive
Tesu Health at Diabetes Professional Care 2024 On 15-16 October 2024, Tesu Health proudly attended Diabetes Professional Care (DPC) at
Patient Enrolment Completed in TH001_1001 Tesu Health is pleased to announce the completion of patient enrolment in the clinical trial
Tesu Health at Cambridge Tech Week 2024 From 9 to 13 September 2024, Cambridge Tech Week brought together some of
Announcing our seed funding round! TESU HEALTH RAISES SEED INVESTMENT AT A $2.5M VALUATION TO FURTHER ITS MISSION OF TRANSFORMING
Tesu Health Joins Cambridge Life Sciences Market Access Programme Tesu Health has been chosen as one of the ten companies
Two New R&D Projects in Chronic Diseases Tesu Health, today announced that two of its research and development projects have